Page last updated: 2024-09-04

edotreotide and Lymphoma, B-Cell, Marginal Zone

edotreotide has been researched along with Lymphoma, B-Cell, Marginal Zone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angelberger, P; Dudczak, R; Kienast, O; Kurtaran, A; Li, M; Li, S; Raderer, M; Schima, W; Traub-Weidinger, T; Virgolini, I1

Trials

1 trial(s) available for edotreotide and Lymphoma, B-Cell, Marginal Zone

ArticleYear
111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Citrates; False Negative Reactions; False Positive Reactions; Female; Gallium; Heterocyclic Compounds; Humans; Indium Radioisotopes; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Octreotide; Peptides, Cyclic; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity

2003